Anti mta2

Manufactured by Abcam

Anti-MTA2 is a primary antibody that recognizes the MTA2 (Metastasis Associated 1 Family Member 2) protein. MTA2 is a component of the NuRD (Nucleosome Remodeling and Deacetylase) complex and is involved in chromatin remodeling and transcriptional regulation.

Automatically generated - may contain errors

Lab products found in correlation

Dynabeads protein g, by Thermo Fisher Scientific (2 mentions) Protease inhibitor mixture cocktail, by Roche (2 mentions) Glutathione sepharose 4b beads, by GE Healthcare (2 mentions) Anti β actin, by Merck Group (1 mentions) Anti flag, by Merck Group (1 mentions) Anti vimentin, by Merck Group (1 mentions) Anti e cadherin, by BD (1 mentions) Anti n cadherin, by BD (1 mentions) Anti fibronectin, by Merck Group (1 mentions) Anti dnmt3b, by Abcam (1 mentions) Short hairpin rnas shrnas, by GenePharma (1 mentions) Anti suz12, by Cell Signaling Technology (1 mentions) Anti wdr77, by Fortis Life Sciences (1 mentions) Anti eed, by Merck Group (1 mentions) Anti prmt5, by Abcam (1 mentions) Anti roc1, by Abcam (1 mentions) Anti ddb1, by Santa Cruz Biotechnology (1 mentions) Anti hdac5, by Abcam (1 mentions) Anti mta3, by Merck Group (1 mentions) Anti mbd2 3, by Merck Group (1 mentions)

2 protocols using anti mta2

Comprehensive Chromatin Remodeling Antibody Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols

The sources of the antibodies were anti-FLAG, anti-HDAC1 anti-HDAC2, anti-RbAp46/48, anti-Fibronectin, anti-Vimentin and anti-β-actin (Sigma–Aldrich); anti-DDB1, anti-MTA1, anti-SIN3A, anti-SAP180 and anti-SAP30 (Santa Cruz Biotechnology); anti-PRMT5, anti-ROC1, anti-LSD1, anti-DNMT3B, anti-HDAC5 and anti-MTA2 (Abcam); anti-EED, anti-MBD2/3 and anti-MTA3 (Millipore); anti-SUZ12 (Cell Signaling Technology); anti-WDR77 (also known as MEP50, Bethyl); anti-MTA2, anti-E-cadherin, anti-α-catenin, anti-γ-catenin, anti-N-cadherin and anti-EZH2 (BD Bioscience); anti-ING4 (Genetex), anti-SETD2 (Proteintech). Dynabeads Protein G was obtained from Invitrogen by Thermo Fisher Scientific, and protease inhibitor mixture cocktail was from Roche Applied Science. Glutathione-Sepharose 4B beads were from GE Healthcare Bio-Sciences. Short hairpin RNAs (shRNAs) were obtained from GenePharma Co Ltd (Shanghai, China).

Gao J., Yang Y., Qiu R., Zhang K., Teng X., Liu R, & Wang Y. (2018). Proteomic analysis of the OGT interactome: novel links to epithelial–mesenchymal transition and metastasis of cervical cancer. Carcinogenesis, 39(10), 1222-1234.

+ Open protocol

+ Expand

Antibody Sources and Inhibitors for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols

Anti-FLAG antibody was purchased from Sigma–Aldrich (Cat. F1804). Anti-SMYD3 (Cat. ab187149), anti-DDB1(Cat. ab109027), anti-METTL3 (Cat. ab195352), anti-HDAC1 (Cat. ab7028), anti-HDAC2 (Cat. ab7029), anti-MTA2 (Cat. ab8106), anti-Histone H4 (Cat. ab177840), and anti-MBD3 (Cat. ab157464) were purchased from Abcam. Anti-CUL4B (Cat. 12916–1-AP), anti-LDHA (Cat. 19987–1-AP), anti-METTL1 (Cat. 14994–1-AP), anti-IGFBP4 (Cat. 18500–1-AP), and anti-β-actin (Cat. 66009–1-lg) were purchased from Proteintech. Anti-MAT1 (Cat. D17G10) and anti-RBBP4 (Cat. 4633-S) were purchased from Cell Signaling Technology. Anti-SIRT1 antibody was purchased from Millipore (Cat. 07–131). anti-Histone H4ac was purchased from ACTIVE MOTIF (Cat. 39243). Glutathione-Sepharose 4B beads were purchased from GE Healthcare Bio-Sciences (Cat. 17–0756-01). Dynabeads Protein G was obtained from Invitrogen by Thermo Fisher Scientific (Cat. 10004D), and the protease inhibitor mixture cocktail was from Roche Applied Science (Cat. 04 693 116 001). Inhibitors of SMYD3, including BCI-121 (Cat. HY-21972) and EPZ031686 (Cat. HY19324), were purchased from MedChemExpress (MCE). siRNAs were purchased from RiboBio (RiboBio Co. Ltd., Guangzhou, Guangdong). siRNA sequences are listed in Additional file 1: Table S1.

Yang Y., Qiu R., Zhao S., Shen L., Tang B., Weng Q., Xu Z., Zheng L., Chen W., Shu G., Wang Y., Zhao Z., Chen M, & Ji J. (2022). SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells. BMC Biology, 20, 294.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!